AAAAAA

   
Results: 1-10 |
Results: 10
Patents on beta-lactam antibacterials: January 1999 to March 2001
Authors: Kim, OK Fung-Tomc, J
Citation: Ok. Kim et J. Fung-tomc, Patents on beta-lactam antibacterials: January 1999 to March 2001, EXPERT OP T, 11(8), 2001, pp. 1267-1276
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams
Authors: Gradelski, E Valera, L Kolek, B Bonner, D Fung-Tomc, J
Citation: E. Gradelski et al., Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams, INT J ANT A, 18(1), 2001, pp. 43-48
Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants
Authors: Fung-Tomc, J Gradelski, E Huczko, E Minassian, B Bonner, DP
Citation: J. Fung-tomc et al., Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants, INT J ANT A, 18(1), 2001, pp. 77-80
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
Authors: Gradelski, E Kolek, B Bonner, DP Valera, L Minassian, B Fung-Tomc, J
Citation: E. Gradelski et al., Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents, INT J ANT A, 17(2), 2001, pp. 103-107
Activity of the novel des-fluoro(6) quinolone BMS-284756 against methicillin-susceptible and -resistant staphylococci
Authors: Fung-Tomc, J Valera, L Minassian, B Bonner, D Gradelski, E
Citation: J. Fung-tomc et al., Activity of the novel des-fluoro(6) quinolone BMS-284756 against methicillin-susceptible and -resistant staphylococci, J ANTIMICRO, 48(5), 2001, pp. 735-738
Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistance
Authors: Gradelski, E Valera, L Aleksunes, L Bonner, D Fung-Tomc, J
Citation: E. Gradelski et al., Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistance, J CLIN MICR, 39(8), 2001, pp. 2961-2963
Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species
Authors: Gradelski, E Valera, L Bonner, D Fung-Tomc, J
Citation: E. Gradelski et al., Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species, ANTIM AG CH, 45(11), 2001, pp. 3220-3222
Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998
Authors: Huczko, E Conetta, B Bonner, D Valera, L Stickle, T Macko, A Fung-Tomc, J
Citation: E. Huczko et al., Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998, INT J ANT A, 16(4), 2000, pp. 401-405
In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin
Authors: Fung-Tomc, J Minassian, B Kolek, B Washo, T Huczko, E Bonner, D
Citation: J. Fung-tomc et al., In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin, J ANTIMICRO, 45(4), 2000, pp. 437-446
Synthesis and anti-MRSA activity of novel cephalosporin derivatives
Authors: D'Andrea, SV Bonner, D Bronson, JJ Clark, J Denbleyker, K Fung-Tomc, J Hoeft, SE Hudyma, TW Matiskella, JD Miller, RF Misco, PF Pucci, M Sterzycki, R Tsai, Y Ueda, Y Wichtowski, JA Singh, J Kissick, TP North, JT Pullockaran, A Humora, M Boyhan, B Vu, T Fritz, A Heikes, J Fox, R Godfrey, JD Perrone, R Kaplan, M Kronenthal, D Mueller, RH
Citation: Sv. D'Andrea et al., Synthesis and anti-MRSA activity of novel cephalosporin derivatives, TETRAHEDRON, 56(31), 2000, pp. 5687-5698
Risultati: 1-10 |